The store will not work correctly when cookies are disabled.
2-(4-(2-Methoxyethyl)piperazine-1-carbonyl)-7-nitro-5-(trifluoromethyl)benzo[d]thiazole 3-oxide
ID: ALA3741206
PubChem CID: 127041763
Max Phase: Preclinical
Molecular Formula: C16H17F3N4O5S
Molecular Weight: 434.40
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: COCCN1CCN(C(=O)c2sc3c([N+](=O)[O-])cc(C(F)(F)F)cc3[n+]2[O-])CC1
Standard InChI: InChI=1S/C16H17F3N4O5S/c1-28-7-6-20-2-4-21(5-3-20)14(24)15-22(25)11-8-10(16(17,18)19)9-12(23(26)27)13(11)29-15/h8-9H,2-7H2,1H3
Standard InChI Key: RRFCZQRJFWMPEM-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 31 0 0 0 0 0 0 0 0999 V2000
1.7138 1.2033 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
2.5889 0.0182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 -1.2033 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 -1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9971 3.0138 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.0337 3.6184 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.0446 3.6095 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.0872 0.0382 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7008 -0.9930 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.8208 1.3475 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.3207 1.3698 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0514 2.6798 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2823 3.9676 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.7825 3.9454 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0518 2.6354 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0107 5.2798 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2393 6.5672 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9677 7.8794 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.3510 8.9088 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0907 -2.3426 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.6202 -1.4892 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.6557 -0.8828 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-3.6279 -2.6892 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-4.6632 -2.0826 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 1 0
1 5 1 0
6 7 1 0
7 8 2 0
8 9 1 0
4 9 2 0
5 6 2 0
10 11 2 0
10 12 1 0
6 10 1 0
13 14 2 0
15 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
15 20 1 0
13 15 1 0
21 22 1 0
23 24 1 0
22 23 1 0
18 21 1 0
2 13 1 0
3 25 1 0
26 27 1 0
26 28 1 0
26 29 1 0
8 26 1 0
M CHG 4 3 1 10 1 12 -1 25 -1
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 434.40 | Molecular Weight (Monoisotopic): 434.0872 | AlogP: 1.87 | #Rotatable Bonds: 5 |
Polar Surface Area: 102.86 | Molecular Species: NEUTRAL | HBA: 7 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 9 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 6.01 | CX LogP: 1.74 | CX LogD: 1.72 |
Aromatic Rings: 2 | Heavy Atoms: 29 | QED Weighted: 0.31 | Np Likeness Score: -1.41 |
References
1. Landge S, Mullick AB, Nagalapur K, Neres J, Subbulakshmi V, Murugan K, Ghosh A, Sadler C, Fellows MD, Humnabadkar V, Mahadevaswamy J, Vachaspati P, Sharma S, Kaur P, Mallya M, Rudrapatna S, Awasthy D, Sambandamurthy VK, Pojer F, Cole ST, Balganesh TS, Ugarkar BG, Balasubramanian V, Bandodkar BS, Panda M, Ramachandran V.. (2015) Discovery of benzothiazoles as antimycobacterial agents: Synthesis, structure-activity relationships and binding studies with Mycobacterium tuberculosis decaprenylphosphoryl-β-D-ribose 2'-oxidase., 23 (24): [PMID:26643218] [10.1016/j.bmc.2015.11.017] |